| XYREM SUCCESS PROGRAM JAZZ PHARMACEUTICALS INC.
1352896 22 Jun 2007 | on 22 Jun 2010 | Class 044 Class 044 Medical, Beauty & Agricultural Services Providing telephone support services to physicians regarding the safe and appropriate use and distribution of medications used to treat sleep disorders; providing medical information via telephone and in the form of written educational materials to physicians in connection with the safe and appropriate use and distribution of medication for the treatment of sleep disorders. | | | XYREM JAZZ PHARMACEUTICALS INC.
1304721 08 Jun 2006 | on 18 Feb 2010 | Class 005 Class 005 Pharmaceutical Products Pain relief medication; preparation for the relief of pain; pharmaceutical preparations for the treatment of disorders affecting the central nervous system, namely drug and alcohol addiction, conduct disorder, oppositional defiant disorder, attention deficit disorders, amnestic disorders, autism, schizophrenia, psychosis, depression, chronic fatigue syndrome, anxiety, irritable bowel disorder, narcolepsy, fibromyalgia, insomnia, and myositis; pharmaceutical preparations for use in the treatment and management of sleep disorders, chronic fatigue syndrome, drug and alcohol abuse, anxiety, cerebrovascular diseases, neurological disorders, namely essential tremor, tic disorders, Tourette's syndrome, Parkinson's disease, Huntington's disease, restless leg syndrome, myoclonus, dystonias, dementia, Alzheimer's disease, learning disabilities, multiple sclerosis, sleep disorders, post surgical pain, post-trauma pain, neuropathic pain and diabetic pain, autism, depression, inflammatory disorders, namely inflammatory bowel disorder, regional ileitis, ulcerative colitis, irritable bowel disorder, autoimmune inflammatory disorders, endocrine disturbances, and diabetes; and pharmaceutical preparations for the purpose of tissue protection namely, tissue protection following hypoxia/anoxia as in the case of stroke, organ transplantation, organ preservation, myocardial infarction or ischemia, reperfusion injury, and protection following radiation, progeria, or an increased level of intracranial pressure as in the case of head trauma. | | | XYREM JAZZ PHARMACEUTICALS INC.
1023221 22 Jul 1999 | on 06 Aug 2002 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of central nervous system indications. | |